A clinical study of a new technology for evaluating oocyte quality based on mitochondrial DNA copy number detection

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046870

Enrollment

Unknown

Registered

2021-05-29

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Gold Standard:Morphological evaluation of oocytes

Index test:MtDNA&#32

detection&#32

of&#32

peripheral&#32

blood&#32

and&#32

granulosa&#32

cells&#32

in&#32

follicular&#32

fluid

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Infertile women who meet the indications of the test-tube baby; 2. Try IVF for the first time; 3. The male semen is normal and free from infectious diseases.

Exclusion criteria

Exclusion criteria: 1. Aged >40 years; 2. With a history of smoking, alcoholism, obesity, irregular sleep; 3. Suffering Osteoporosis, diabetes, cancer, cardiovascular and cerebrovascular diseases, neurodegenerative diseases and mental diseases, etc.

Design outcomes

Primary

Measure	Time frame
Copy number of mtDNA in peripheral blood;Copy number of mtDNA of granulosa cells in follicular fluid;	—

Countries

China

Contacts

Public ContactMa Yanmin

Beijing Obstetric & Gynecology Hospital, Capital Medical University

minyanma@163.com+86 18811062418

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026